Next Article in Journal
Antiviral Action against SARS-CoV-2 of a Synthetic Peptide Based on a Novel Defensin Present in the Transcriptome of the Fire Salamander (Salamandra salamandra)
Previous Article in Journal
Nanocarrier Design for Dual-Targeted Therapy of In-Stent Restenosis
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Retraction

RETRACTED: Fahmy et al. Intranasal Niosomal In Situ Gel as a Promising Approach for Enhancing Flibanserin Bioavailability and Brain Delivery: In Vitro Optimization and Ex Vivo/In Vivo Evaluation. Pharmaceutics 2020, 12, 485

by
Usama A. Fahmy
1,2,
Shaimaa M. Badr-Eldin
1,3,*,
Osama A. A. Ahmed
1,2,
Hibah M. Aldawsari
1,4,
Singkome Tima
5,
Hani Z. Asfour
6,
Mohammed W. Al-Rabia
6,
Aya A. Negm
7,
Muhammad H. Sultan
8,
Osama A. A. Madkhali
8 and
Nabil A. Alhakamy
1,2,4,9
1
Department of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia
2
Advanced Drug Delivery Research Group, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia
3
Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, Cairo 11562, Egypt
4
Center of Excellence for Drug Research and Pharmaceutical Industries, King Abdulaziz University, Jeddah 21589, Saudi Arabia
5
Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai 50200, Thailand
6
Department of Medical Microbiology and Parasitology, Faculty of Medicine, King Abdulaziz University, Jeddah 21589, Saudi Arabia
7
Department of Pharmacognosy, Faculty of Pharmacy, Zagazig University, Zagazig 44518, Egypt
8
Department of Pharmaceutics, College of Pharmacy, Jazan University, Jazan 45142, Saudi Arabia
9
King Fahd Medical Research Center, King Abdulaziz University, Jeddah 21589, Saudi Arabia
*
Author to whom correspondence should be addressed.
Pharmaceutics 2024, 16(2), 189; https://doi.org/10.3390/pharmaceutics16020189
Submission received: 15 January 2024 / Accepted: 16 January 2024 / Published: 29 January 2024
This journal retracts the article “Intranasal Niosomal In Situ Gel as a Promising Approach for Enhancing Flibanserin Bioavailability and Brain Delivery: In Vitro Optimization and Ex Vivo/In Vivo Evaluation” [1], cited above.
Following publication, concerns were brought to the attention of the publisher regarding the overlap of images.
Adhering to our complaint’s procedure, an investigation was conducted by the Editorial Office and the Editorial Board that confirmed the overlap of an image (Figure 5) with the prior [2] and later publications [3].
While the authors fully cooperated with the Editorial Office during the investigation, they were unable to satisfactorily explain the overlap of figures nor could the required quality standards of raw images in order to consider a correction as per the journals original image requirements policy be met (https://www.mdpi.com/journal/pharmaceutics/instruc-tions#oriimages). As a result, the Editorial Board and EIC were unable to confirm the reliability of the findings and subsequently decided to retract this paper.
This retraction was approved by the Editor-in-Chief of the journal Pharmaceutics.
The authors did not agree to this retraction.

References

  1. Fahmy, U.A.; Badr-Eldin, S.M.; Ahmed, O.A.A.; Aldawsari, H.M.; Tima, S.; Asfour, H.Z.; Al-Rabia, M.W.; Negm, A.A.; Sultan, M.H.; Madkhali, O.A.A.; et al. RETRACTED: Intranasal Niosomal In Situ Gel as a Promising Approach for Enhancing Flibanserin Bioavailability and Brain Delivery: In Vitro Optimization and Ex Vivo/In Vivo Evaluation. Pharmaceutics 2020, 12, 485. [Google Scholar] [CrossRef] [PubMed]
  2. Fahmy, U.A.; Alaofi, A.L.; Awan, Z.A.; Alqarni, H.M.; Alhakamy, N.A. Retraction Note: Optimization of Thymoquinone-Loaded Coconut Oil Nanostructured Lipid Carriers for the Management of Ethanol-Induced Ulcer. AAPS PharmSciTech 2023, 24, 129. [Google Scholar] [CrossRef] [PubMed]
  3. Awan, Z.A.; Fahmy, U.A.; Badr-Eldin, S.M.; Ibrahim, T.S.; Asfour, H.Z.; Al-Rabia, M.W.; Alfarsi, A.; Alhakamy, N.A.; Abdulaal, W.H.; Al Sadoun, H.; et al. The Enhanced Cytotoxic and Pro-Apoptotic Effects of Optimized Simvastatin-Loaded Emulsomes on MCF-7 Breast Cancer Cells. Pharmaceutics 2020, 12, 597. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Fahmy, U.A.; Badr-Eldin, S.M.; Ahmed, O.A.A.; Aldawsari, H.M.; Tima, S.; Asfour, H.Z.; Al-Rabia, M.W.; Negm, A.A.; Sultan, M.H.; Madkhali, O.A.A.; et al. RETRACTED: Fahmy et al. Intranasal Niosomal In Situ Gel as a Promising Approach for Enhancing Flibanserin Bioavailability and Brain Delivery: In Vitro Optimization and Ex Vivo/In Vivo Evaluation. Pharmaceutics 2020, 12, 485. Pharmaceutics 2024, 16, 189. https://doi.org/10.3390/pharmaceutics16020189

AMA Style

Fahmy UA, Badr-Eldin SM, Ahmed OAA, Aldawsari HM, Tima S, Asfour HZ, Al-Rabia MW, Negm AA, Sultan MH, Madkhali OAA, et al. RETRACTED: Fahmy et al. Intranasal Niosomal In Situ Gel as a Promising Approach for Enhancing Flibanserin Bioavailability and Brain Delivery: In Vitro Optimization and Ex Vivo/In Vivo Evaluation. Pharmaceutics 2020, 12, 485. Pharmaceutics. 2024; 16(2):189. https://doi.org/10.3390/pharmaceutics16020189

Chicago/Turabian Style

Fahmy, Usama A., Shaimaa M. Badr-Eldin, Osama A. A. Ahmed, Hibah M. Aldawsari, Singkome Tima, Hani Z. Asfour, Mohammed W. Al-Rabia, Aya A. Negm, Muhammad H. Sultan, Osama A. A. Madkhali, and et al. 2024. "RETRACTED: Fahmy et al. Intranasal Niosomal In Situ Gel as a Promising Approach for Enhancing Flibanserin Bioavailability and Brain Delivery: In Vitro Optimization and Ex Vivo/In Vivo Evaluation. Pharmaceutics 2020, 12, 485" Pharmaceutics 16, no. 2: 189. https://doi.org/10.3390/pharmaceutics16020189

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop